Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Communication

October 24th 2012

Facebook , Twitter, the last few years have shown the ease of communication using technology where all aspects of someone can be followed on line and where a person’s once confidential information now seems to be open to the world. Compare that to communication between health care professionals involved in a patients care. This is of particular importance when it comes to diabetes and the multi-disciplinary approach taken including input from doctors, nurses, podiatrists, dieticians, retinal screeners – the list goes on. The information divide is most marked between primary care (where most practices are paperless) and secondary care (where paper predominates or a variety of clinical information tools exist). The major issue from all these different systems is the lack of continuity of care, duplication of care (such as foot screening) and delays in passing on changes to a patients’ management.

Of course primary care systems vary around the country but often in certain areas, a single system may predominate, such as Systmone (http://www.tpp-uk.com). So, how difficult is it to actually share information? The answer is not very, although there are a number of hoops that need to be jumped through especially when considering the thorny problem of consent and data protection. Whilst many patients already feel that their information flows freely between their health care providers, this is not usually the case. In fact agreement to allow data sharing usually requires sign up from a variety of organisations e.g. PCT, CCG and acute trust as well as having a way of documenting it on an individual basis in the patient records.

So, once everyone is using the same system, who benefits?

The patient. Reduced duplication of activity where the practice and specialists are concentrating on the most appropriate aspect of care e.g. BP or glycaemic control.

Primary care. Rapid communication from other health care professionals in the MDT. This includes clinical activity performed elsewhere (useful for QoF) , rapid updating of changes to medication and saving of clerical time scanning letters.

Secondary care. Access to more accurate clinical data including that from other organisations e.g. tertiary centres and a more seamless way of diabetes care. Given the movement of much routine care back to primary care, sharing of clinical records allows specialist team to offer a more refined service. This includes the use of e-consultations – some areas are already commissioning this from the specialist teams.

Thus, the use of technology and communication is readily applicable to the world of diabetes care (and probably other chronic diseases). However the increasingly complex commissioning arrangements of the new world may result in more problems than answers.

Dr Mark Freeman

Categories: Updates

Diabetes Updates Archive

calendar-iconDiabetes Updates Archive ››

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Gold Sponsors

Napp DiabetesNovo NordiskAstraZenecaBoehringer Ingelheim

Silver Sponsors

About Ascensia Diabetes CareAbbott Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2022 Glycosmedia Partnership